Evaluation of performance of automatic fusion for radiofrequency ablation of hepatocellular carcinoma

Evaluation of performance of S-fusionTM for radiofrequency ablation of hepatocellular carcinoma: A randomized, prospective study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001734

Enrollment

Registered

2015-12-16

Start date

2016-02-12

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : Radiofrequncy ablation for hepatic malignancies will be perfomred with 1) manual registration (control), and 2) automatic registration (experimental). Except the im

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) more than 40-years old 2) Patients with hepatic malignancy who will underwent radiofrequency ablation

Exclusion criteria

Exclusion criteria: 1) Not using fusion imaging (CT guidance or fluorosopic guidance)

Design outcomes

Primary

Measure	Time frame
Registration time;Registraion accuracy	—

Secondary

Measure	Time frame
Technical success;Technical effectiveness;Local tumor progression rate	—

Countries

Korea, Republic of

Contacts

Public ContactJoon-Il

The Catholic University of Korea

dumkycji@gmail.com+82-2-2258-1431

Outcome results